Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05437198 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Microbiological Diversity in Exhaled Air in COPD and Free of COPD

Study acronym: EXHALBIO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Jun 11, 2025, no change to tracked fieldsv6-v7
  2. Trial status: Not Yet Recruiting to Recruitingv5 Show 4 more changesShow less
    • Start date changed from estimate of Oct 2023 to Mar 26, 2024
    • Study sites: 0 to 1
    • Primary completion date: Oct 2027 to Mar 2028
    • Study completion date: Oct 2028 to Mar 2029
  3. Primary completion date: Feb 2027 to Oct 2027
    • Start date: Feb 2023 to Oct 2023
    • Study completion date: Feb 2028 to Oct 2028
    v4
  4. Start date: Oct 2022 to Feb 2023
    • Primary completion date: Oct 2026 to Feb 2027
    • Study completion date: Mar 2028 to Feb 2028
    v3
  5. Eligibility criteria expanded, about 15 words
    • Study title shortened, about 5 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
COPD and non-COPD patients will be included in the study after collection of their non-objection. The exhalation will be collected to study the microbiological diversity of human exhalations. a second collection for the year +1 will be made, at the same time (between October and March).
Trial Details
NCT Number NCT05437198
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions
(from sponsor)		 Chronic Obstructive Pulmonary Disease
Related terms Pulmonary Disease, Chronic Obstructive
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov